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Abstract:
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon cytokine storm
syndrome marked by high mortality. In adults, acquired HLH usually has an
underlying infectious, autoimmune or malignant process that triggers the
syndrome. In this case report, we present a 64-year old Caucasian male presenting
with productive cough, fevers, weight loss and altered mental status who was
ultimately found to have HLH of unknown etiology.
Introduction:
According to the 2008 diagnostic criteria, HLH is established by a molecular
diagnosis of pathologic mutation or through clinical and laboratory findings of fever,
splenomegaly, cytopenias, hypertriglyceridemia and/or hypofibrinogenemia, tissue
diagnosis of hemophagoyctosis in the bone marrow, spleen or lymph nodes, low or
absent natural killer cell activity, elevated ferritin (>500 ng/ mL), and soluble CD 25
> 2400 U/mL. As a cytokine storm syndrome, HLH is often confused for sepsis,
macrophage-activation syndrome (MAS) and other multi-organ system failures.
Early recognition of HLH can prompt timely treatment and improve morbidity and
mortality. Current therapeutic options include immunosuppression, immune
modulation, chemotherapy, and biological response modification followed by bone
marrow transplant.
Case Report:
A 64-year old Caucasian gentleman presented to the Emergency Department with
complaints of lethargy, weakness, progressive dyspnea on exertion, productive
cough of whitish sputum and a fever of 102.5 F. His past medical history was
significant for non-insulin dependent diabetes, CAD s/p stent 14 years prior,
hypertension, and atrial fibrillation. He had a 14 pack year smoking history and had
quit smoking 13 years prior. On review of systems, he admitted to a 5 lbs weight
loss over the past 3 months, intermittent bouts of confusion and recent leg swelling.
Deep venous thrombosis was excluded by his primary care physician, a week prior
to admission. While in the ED, a CBC showed pancytopenia, marked by a white blood
cell count of 2.7 and anemia with hemoglobin of 10.1. A CXR was performed
showing bilateral pulmonary nodules; a CT scan of his chest and abdomen showed
extensive pulmonary nodules and moderate splenomegaly. The patient was started
on empiric antibiotics for presumed pneumonia with concerns of sepsis.
An exhaustive approach for a possible malignant etiology of the patient’s
lymphadenopathy was initiated on the second day of hospitalization. A CT-guided
lung biopsy and bone marrow biopsy were initially conducted which were negative
for any abnormal cells. Additionally, a PET-CT, VATS procedure, and several more

bone marrow biopsies were performed, without any explanation for his symptoms.
An extensive rheumatologic work up only showed mild positivity for anticardiolipin IgG and beta-2 glycoprotein 1 antibody IgA positivity. Infectious work up
for Rickettsia, Histoplasmosis, Blastomycosis, Bartonella, Syphillis, Tuberculosis,
Babesiosis, fungal, viral, and other potential infectious etiologies were unrevealing.
Of interest, the patient had one AFB positive sample from his VATS procedure after
two weeks, however this specimen was concluded to be non-correlative. All repeat
AFB cultures and sputum analyses were negative. His hospital course was
prolonged and complicated by bouts of altered mental status, continuing fevers and
worsening pancytopenia.
Approximately three hospital re-admissions for sepsis-like syndrome, a
splenectomy was performed with pathology showing hemophagocytosis. At the
time of the splenectomy, an elevated ferritin value of > 70000 was noted, and
fibrinogen levels were low. The patient was additionally found to have an elevated
IL-2R. Thus, a diagnosis of HLH was made given pancytopenia, ferritin of 70000,
elevated triglycerides, hypofibrinogenemia, elevated IL-2R, splenomegaly,
hemophagocytosis on splenectomy and fevers. The patient was treated with
etoposide and dexamethasone by his oncologist, per protocol, to which his
cytopenia, ferritin and fibrinogen improved.
Conclusion:
HLH is a rare disease entity that is often confused for sepsis syndrome. An extensive
work up is urgent and necessary to adequately treat patients to reduce morbidity
and mortality.
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